+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Monoclonal Antibody Collaboration and Licensing Deals 2019-2026

  • PDF Icon

    Report

  • 350 Pages
  • May 2026
  • Region: Global
  • CurrentPartnering
  • ID: 2563605

The definitive benchmark for monoclonal antibody dealmaking

Monoclonal antibody partnering is driven by a well-established yet continuously evolving class of biologic therapies, with deal structures reflecting both mature development pathways and ongoing innovation in next-generation antibody formats.

This report provides a comprehensive and structured analysis of 740+ monoclonal antibody collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how monoclonal antibody deals are structured in practice, allowing you to:

  • Benchmark comparable transactions with confidence
  • Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
  • Define realistic market parameters
  • Clear insight into how deal terms vary by development stage, antibody type, and partner profile
  • Support valuation and structuring decisions with evidence
  • Ground internal discussions in real transaction data rather than assumptions
  • Understand how leading companies approach dealmaking
  • Visibility into partner behaviour and recurring deal structures across a competitive and innovation-driven biologics landscape
  • Full visibility into deal structure and execution
Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

  • Rights granted and retained
  • Development and commercialization responsibilities
  • Financial structures and payment triggers
  • Key contractual provisions and protections
This level of transparency is critical to understanding how value, risk, and control are allocated within monoclonal antibody partnerships, particularly in areas involving differentiated biologics and evolving therapeutic strategies.

Designed for real-world BD and strategy use

The report is widely used to:

  • Structure and benchmark biologics transactions
  • Prepare for negotiations with well-defined market context
  • Evaluate licensing and co-development opportunities
  • Support internal strategy with robust, defensible data

What’s included?

  • 740+ monoclonal antibody collaboration and licensing deals
  • Financial terms, including upfronts, milestones, and royalties where disclosed
  • Fully searchable deal directory (by company, therapy, and antibody type)
  • Direct access to SEC-filed agreements and source documents
  • Analysis of deal trends, key transactions, and active dealmakers
  • A trusted, evidence-based reference for monoclonal antibody dealmaking
Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how monoclonal antibody partnerships are structured, negotiated, and valued.

Table of Contents

Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in monoclonal antibody dealmaking
2.1. Introduction
2.2. Monoclonal antibody deals over the years
2.3. Most active monoclonal antibody dealmakers
2.4. Monoclonal antibody deals by deal type
2.5. Monoclonal antibody deals by therapy area
2.6. Monoclonal antibody deals by industry sector
2.7. Deal terms for monoclonal antibody deals
2.7.1 Monoclonal antibody deals headline values
2.7.2 Monoclonal antibody deal upfront payments
2.7.3 Monoclonal antibody deal milestone payments
2.7.4 Monoclonal antibody royalty rates
Chapter 3 - Leading monoclonal antibody deals
3.1. Introduction
3.2. Top monoclonal antibody deals by value
Chapter 4 - Most active monoclonal antibody dealmakers
4.1. Introduction
4.2. Most active monoclonal antibody dealmakers
4.3. Most active monoclonal antibody deals company profiles
Chapter 5 - Monoclonal antibody contracts dealmaking directory
5.1. Introduction
5.2. Monoclonal antibody contracts dealmaking directory
Chapter 6 - Monoclonal antibody dealmaking by technology type
Deal directory
  • Deal directory - Monoclonal antibody deals by company A-Z
  • Deal directory - Monoclonal antibody deals by deal type
  • Deal directory - Monoclonal antibody deals by therapy area
  • Deal type definitions
List of Figures
Figure 1: Monoclonal antibody deals since 2019
Figure 2: Active monoclonal antibody dealmaking activity since 2019
Figure 3: Monoclonal antibody deals by deal type since 2019
Figure 4: Monoclonal antibody deals by therapy area since 2019
Figure 5: Monoclonal antibody deals by industry sector since 2019
Figure 6: Monoclonal antibody deals with a headline value
Figure 7: Monoclonal antibody deals with an upfront value
Figure 8: Monoclonal antibody deals with a milestone value
Figure 9: Monoclonal antibody deals with a royalty rate value
Figure 10: Top monoclonal antibody deals by value since 2019
Figure 11: Most active monoclonal antibody dealmakers since 2019
Figure 12: Monoclonal antibody deals by technology type since 2019

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 1ST Biotherapeutics
  • 3D Medicines
  • 3rd People’s Hospital of Shenzhen
  • 3SBio
  • 4D Pharma
  • 9 Meters Biopharma
  • A*STAR Agency for Science
  • Technology and Research
  • A*STAR Bioprocessing Technology Institute
  • Abbvie
  • AbCellera Biologics
  • Abdul Latif Jameel Health
  • ABL Bio
  • Ablexis
  • Aboundbio
  • Ab Studio
  • AbTherx
  • Abveris
  • Abzena
  • Accurus Biosciences
  • AcedrA BioPharmaceuticals
  • Acerta Pharma
  • AchilleS Vaccines
  • Aclaris Therapeutics
  • Acumen Pharmaceuticals
  • Adagene
  • ADEL
  • Adimab
  • Adlai Nortye
  • Advanz Pharma
  • Advaxis
  • Aegis Life
  • Aevi Genomic Medicine
  • AffaMed Therapeutics
  • AGC Biologics
  • Agenus Bio
  • Agilent Technologies
  • AgomAb Therapeutics
  • AimedBio
  • AIM ImmunoTech
  • Aimmune Therapeutics
  • Ajinomoto
  • Akeso Biopharma
  • Akston Biosciences
  • Alchemab Therapeutics
  • Alector
  • Alexion Pharmaceuticals
  • Alfasigma
  • AlivaMab Discovery Services
  • Alkyon Therapeutics
  • Alligator Bioscience
  • Allinaire Therapeutic
  • Alloy Therapeutics
  • Almac Group
  • Almirall
  • Alphamab Biopharmaceuticals
  • Alpine Immune Sciences
  • Alteogen
  • Alvotech
  • ALX Oncology
  • Alzheimer's Drug Discovery Foundation
  • AmerisourceBergen
  • Amgen
  • AmMax Bio
  • Amneal Pharmaceuticals
  • Amolyt Pharma
  • Amplyx Pharmaceuticals
  • AnaptysBio
  • Angios
  • Ankyra Therapeutics
  • Antengene
  • Antidote Therapeutics
  • Apeiron Biologics
  • Apexigen
  • Apollo Therapeutics
  • Applied BioMath
  • APRINOIA Therapeutics
  • Aptevo Therapeutics
  • Arch Oncology
  • Arcus Biosciences
  • Arecor Therapeutics
  • argenx
  • Aridis Pharmaceuticals
  • Arovella Therapeutics
  • Ascendant Health Sciences
  • Ascentage Pharma
  • Asher Biotherapeutics
  • Asieris MediTech
  • Aslan Pharma
  • ASLAN Pharmaceuticals
  • Astellas Pharma
  • AstraZeneca
  • Astria Therapeutics
  • Atlante Biotech
  • Atlas Antibodies
  • Atossa Therapeutics
  • Atreca
  • ATUM
  • Augmenta
  • Avalo Therapeutics
  • Avantor
  • AVEO Oncology
  • Avid Bioservices
  • Avidity Biosciences
  • Axantia
  • Banner Alzheimer's Institute
  • Basilea Pharmaceutica
  • Bausch & Lomb
  • Bayer
  • Beckman Coulter
  • BeiGene
  • Beijing InnoCare Pharma
  • Beijing Mabworks Biotech
  • Beijing Tianshi Tongda Pharmaceuticals Technology
  • BeOne Medicines
  • Betta Pharmaceuticals
  • Bill and Melinda Gates Foundation
  • Binex
  • Bio-Manguinhos/Fiocruz
  • Bio-Thera Solutions
  • BioArctic AB
  • BioAtla
  • BioCity Biopharma
  • Biocon
  • BioCryst Pharmaceuticals
  • Biocytogen
  • Bioelectronica
  • Bioeq IP
  • Biogen
  • BioInvent
  • Biomedical Advanced Research and Development Authority
  • Biomm
  • Biomunex Pharmaceuticals
  • Bioncotech Therapeutics
  • Biond Biologics
  • Bionoveo
  • BioNTech
  • BiosanaPharma
  • Biosidus
  • Biosion
  • Biotheus
  • Biotools
  • BioXcel
  • BJ Bioscience
  • Blackstone
  • Bluebird Bio
  • BlueJay Therapeutics
  • Boehringer Ingelheim
  • Bolt Biotherapeutics
  • Boston Immune Technologies and Therapeutics
  • Bpifrance
  • BridgeBio Pharma
  • Brigham and Women's Hospital
  • Bright Peak Therapeutics
  • Brii Biosciences
  • Bristol-Myers Squibb
  • C-Bridge Capital
  • Calico
  • Calypso Biotech
  • CanariaBio
  • Cancer Focus Fund
  • Cancer Prevention and Research Institute of Texas
  • Cancer Research UK
  • Cancer Science Institute of Singapore
  • CanCure
  • Care Access Research
  • Caris Life Sciences
  • CARsgen
  • Cartexell
  • CASI Pharmaceuticals
  • Catalent
  • Cedars-Sinai Medical Center
  • Celgene
  • Celiac Disease Foundation
  • Cellectis
  • Celltrion
  • Celsius Therapeutics
  • Celularity
  • Cend Therapeutics
  • Cessation Therapeutics
  • CG Oncology
  • Champions Oncology
  • Checkmate Pharmaceuticals
  • Checkpoint Therapeutics
  • Chi-Med
  • Chiesi Farmaceutici
  • Chime Biologics
  • China Resources Pharmaceutical Commercial Group International Trading
  • Chiome Bioscience
  • Cipla
  • Circio
  • City of Hope Comprehensive Cancer Center
  • Climb Bio
  • Clinical Trial and Consulting Services
  • Clinica Universidad Navarra
  • CMAB Biopharma
  • Coherus Biosciences
  • Compass Therapeutics
  • Compugen
  • Convergent Therapeutics
  • CounterX Therapeutics
  • Creative Biolabs
  • Cristalia
  • Cromos Pharma
  • CSL
  • CSPC Pharmaceutical Group
  • CStone Pharmaceuticals
  • Cue Biopharma
  • Curative Biotechnology
  • Cure Duchenne
  • CureVac
  • Curia
  • Curis
  • Cytea Bio
  • Cytodyn
  • Cytovation
  • Daiichi Sankyo
  • Defense Advanced Research Projects Agency
  • Department of Defense
  • Dermira
  • Disc Medicine
  • Dong-A ST
  • Dr. Falk Pharma
  • Dr. Reddy's Laboratories
  • Dragonfly Therapeutics
  • Duke University
  • Duoning Biotechnology
  • E25Bio
  • Earendil Labs
  • EirGenix
  • Eisai
  • Elanco
  • Eledon Pharmaceuticals
  • Elektrofi
  • Elevar Therapeutics
  • Elevation Oncology
  • Elicio Therapeutics
  • Eli Lilly
  • Emergent BioSolutions
  • Enable Injections
  • Enlivex
  • Entos Pharmaceuticals
  • Enzene Biosciences
  • Enzolytics
  • EQRx
  • Equillium
  • Erasca
  • Erasmus University Medical Center
  • EsoCap
  • Eucure Biopharma
  • European Union Regional Development Fund
  • EUSA Pharma
  • Evaxion Biotech
  • Everest Medicines
  • Eversana
  • Evopoint Biosciences
  • Evotec
  • ExCEEd Orphan
  • Excellmab
  • Exelixis
  • F-Star Therapeutics
  • FairJourney Biologics
  • FatiAbGen
  • Five Prime Therapeutics
  • Flare Therapeutics
  • FLX Bio
  • Formation Bio
  • Formosa Pharmaceuticals
  • Formycon
  • Forty Seven
  • Fosun Kite Biotechnology
  • Fosun Pharmaceutical
  • Foundery Innovations
  • French National Blood Service
  • Fresenius Kabi Pharmaceuticals
  • Frontage Clinical Services
  • Fuji Pharma
  • Fujirebio Diagnostics
  • Fusion Pharmaceuticals
  • FutureGen Biopharm
  • Galecto
  • Gates Medical Research Institute
  • GC Cell
  • Gedeon Richter
  • Genagon Therapeutics
  • Genentech
  • Generation Biotech
  • GenFleet Therapeutics
  • Genmab
  • Gennao Bio
  • Genome and Company
  • Genprex
  • Gensci
  • GenScript Biotech
  • GenScript ProBio
  • Georgetown University
  • GI Innovation
  • Gilead Sciences
  • Goldfinch Bio
  • Gossamer Bio
  • GO Therapeutics
  • Granite Bio
  • GSK
  • Halozyme Therapeutics
  • Harbour Biomed
  • HBM Alpha Therapeutics
  • Hengenix Biotech
  • Henlius Biotech
  • HiberCell
  • HIBio
  • HiFiBio
  • Highlight Therapeutics
  • High Line Bio
  • Hikma Pharmaceuticals
  • Hisun BioRay
  • Hoffmann La Roche
  • Hookipa Pharma
  • Hope Medicine
  • Horizon Discovery
  • Horizon Therapeutics
  • Huadong Medicine
  • Hualan Genetic
  • Humanigen
  • Hummingbird Bioscience
  • Huyabio International
  • Hypospray Pharma
  • I-mab
  • Iambic Therapeutics
  • iBio
  • IcanoMAB
  • Ichnos Sciences
  • Ichor Medical Systems
  • IDBiologics
  • IDEAYA Biosciences
  • Igyxos
  • ImCheck Therapeutics
  • IMIDomics
  • Immatics Biotechnologies
  • Immix Biopharma
  • ImmPACT Bio
  • Immune-Onc Therapeutics
  • ImmuneCyte Life Sciences
  • Immuneering
  • ImmuneOncia Therapeutics
  • Immunitas Therapeutics
  • ImmunityBio
  • Immunocore
  • Immunome
  • Immunomedics
  • ImmunoPrecise Antibodies
  • Immutep
  • Imugene
  • IMV
  • Incyte
  • Indaptus Therapeutics
  • Indiana University
  • Indian Institute of Science Education and Research
  • Infex Therapeutics
  • Infinimmune
  • InflamaCORE
  • InflaRx
  • Inhalon Biopharma
  • Initium Therapeutics
  • Innovent Biologics
  • Inovio
  • InSilicoTrials
  • Inspirna
  • Institut Bergonie
  • Institute for Basic Science
  • Intas Pharmaceuticals
  • Integral Molecular
  • INTELLiSTEM
  • Intensity Therapeutics
  • IntoCell
  • Intract Pharma
  • Invetx
  • InxMed
  • IO Biotech
  • Ionova
  • IONTAS
  • Ipsen
  • IRBM
  • Italian Association for the Study of Pancreas
  • iTeos Therapeutics
  • Jacobio Pharmaceuticals
  • Janssen Biotech
  • Janssen Research & Development
  • Jasper Therapeutics
  • Jazz Pharmaceuticals
  • JCR Pharmaceuticals
  • Jemincare
  • Jiangsu Alphamab
  • Jiangsu Hansoh Pharmaceutical
  • Jiangsu Hengrui Pharmaceuticals
  • Johnson & Johnson
  • Johnson & Johnson Innovation
  • Jounce Therapeutics
  • Junshi Biosciences
  • Just Biotherapeutics
  • Juvenile Diabetes Research Foundation
  • KAHR Medical
  • Kaken Pharmaceutical
  • Kalbe Genexine Biologics
  • KaliVir Immunotherapeutics
  • KangaBio
  • Kashiv BioSciences
  • KBI BioPharma
  • KBio
  • KdT Ventures
  • Kelun-Biotech Biopharmaceutical
  • Kennedy Institute of Rheumatology
  • Kiadis Pharma
  • Kindred Bio
  • Kineta
  • Kiniksa Pharmaceuticals
  • Kintor
  • Kissei Pharmaceutical
  • Kite Pharma
  • Kleo Pharmaceuticals
  • Kling Biotherapeutics
  • Kodiak Sciences
  • KPM Tech
  • Kyowa Hakko Kirin
  • Kyttaro
  • Laekna
  • Lassen Therapeutics
  • Lava Therapeutics
  • LenioBio
  • LEO Pharma
  • Leukemia & Lymphoma Society
  • Leveragen
  • LifeMax Laboratories
  • Ligand Pharmaceuticals
  • Link Cell Therapies
  • Linnaeus Therapeutics
  • Liverpool School of Tropical Medicine
  • Livzon Mabpharm
  • Lobesity Pharma
  • Lonza
  • LOTTE Biologics
  • Lunit
  • Lupus Therapeutics
  • Lyvgen Biopharma
  • MAB Discovery
  • MAbSilico
  • mAbsolve
  • Mabwell Bioscience
  • mAbXience
  • Mabylon
  • Macrogenics
  • MAIA Biotechnology
  • mAIbe
  • Makana Therapeutics
  • Manhattan BioSolutions
  • Mapp Biopharmaceutical
  • Massachusetts General Hospital
  • Matrix Medical Network
  • Mayo Clinic
  • McLean Hospital
  • MD Anderson Cancer Center
  • Mediar Therapeutics
  • Medical Research Council
  • Medicenna Therapeutics
  • MediLink Therapeutics
  • Medimabs
  • Medison Pharma
  • Meiji Seika
  • Merck and Co
  • Merck KGaA
  • Merck Sharpe & Dohme
  • Mereo BioPharma
  • Merus
  • Microbiotica
  • Mirror Biologics
  • Mitsubishi Tanabe Pharma
  • Molcure
  • Monopar Therapeutics
  • MoonLake Immunotherapeutics
  • MorphoSys
  • Mount Sinai Health System
  • MSD
  • MS Pharma
  • Mundipharma
  • Mustang Bio
  • myTomorrows
  • Nanjing Leads Biolabs
  • Nantes University
  • Nascent Biotech
  • National Cancer Institute
  • National Comprehensive Cancer Network (NCCN)
  • National Heart
  • Lung and Blood Institute
  • National Institute for Bioprocessing Research and Training
  • National Institute of Allergy and Infectious Diseases
  • National Institute on Drug Abuse (NIDA)
  • National Institutes of Health
  • National University Cancer Institute
  • Navrogen
  • Nectin Therapeutics
  • Nektar Therapeutics
  • Nelum Pharma
  • NeoImmuneTech
  • Neoleukin Therapeutics
  • Neopharmed Gentili
  • Neotope
  • NETRIS Pharma
  • Neuraxpharm
  • Neurimmune Therapeutics
  • Neximmune
  • NGM Biopharmaceuticals
  • NiKang Therapeutics
  • Nipro Corporation
  • Nkarta Therapeutics
  • NKGen Biotech
  • NKMax America
  • Nobelpharma
  • Noetik
  • Nona Biosciences
  • Nordic Society of Gynaecological Oncology
  • Norgine
  • NorthStar Medical Radioisotopes
  • Nouscom
  • NovalGen
  • Novartis
  • Novelty Nobility
  • Novocure
  • Novo Nordisk
  • Noxopharm
  • Numab
  • Nykode Therapeutics
  • OBI Pharma
  • Olatec Therapeutics
  • Olivia Newton-John Cancer Research Institute
  • Ology Bioservices
  • Omeros
  • OncoC4
  • Oncologie
  • Oncolytics Biotech
  • OncoResponse
  • OncoSec Medical
  • OncoVent
  • OncoVerity
  • Oncternal Therapeutics
  • OncXerna Therapeutics
  • Ono Pharmaceutical
  • Ordaos Bio
  • ORIC Pharmaceuticals
  • Orient EuroPharma
  • Orion
  • Oruka Therapeutics
  • OSE Immunotherapeutics
  • Outlook Therapeutics
  • Oxford BioTherapeutics
  • Palleon Pharmaceuticals
  • Pandion Therapeutics
  • Parexel
  • Parexel Biotech
  • Partner Therapeutics
  • Percheron Therapeutics
  • Personal Genome Diagnostics
  • Personalis
  • Pfizer
  • Phanes Therapeutics
  • PharmAbcine
  • PharmaEssentia
  • Pharmapark
  • PhaseBio Pharmaceuticals
  • Pieris Pharmaceuticals
  • Pierre Fabre
  • Pionyr Immunotherapeutics
  • PlantForm
  • PlantPraxis Biotecnologia
  • PMV Pharma
  • Pneuma Respiratory
  • POINT Biopharma
  • Polpharma
  • Polpharma Biologics
  • Portage Biotech
  • Precision BioSciences
  • Prellis Biologics
  • Prelude Therapeutics
  • Prestige BioPharma
  • ProBioGen
  • Progenetics
  • Promega
  • Prometheus Biosciences
  • Prothena
  • Provention Bio
  • PT Etana Biotechnologies
  • Purdue University
  • PureTech Health
  • Pyxis Oncology
  • Q32 Bio
  • QBiotics
  • QIAGEN
  • Quantum Leap Health Care Collaborative
  • Qurient
  • R-Pharm
  • Rakuten Medical
  • Rallybio
  • Rani Therapeutics
  • Rapid Novor
  • RAPT Therapeutics
  • RefleXion Medical
  • Regeneron Pharmaceuticals
  • Regenxbio
  • Regnum
  • Releviate Therapeutics
  • RemeGen
  • Roche
  • Rockefeller University
  • Rocket Pharmaceuticals
  • Roswell Park Cancer Institute
  • Royalty Pharma
  • RQ Biotechnology
  • RTW Investments
  • RubrYc Therapeutics
  • Rxilient Biotech
  • Rznomics
  • SAB Biotherapeutics
  • Saccharo
  • Saga University
  • Samsung Bioepis
  • Samsung Biologics
  • Samyang Biopharmaceuticals
  • San Diego Biomedical Research Institute
  • Sandoz
  • Sanofi
  • Sanofi US Services
  • Sanyou Biopharmaceuticals
  • SATT Conectus Alsace
  • SaudiVax
  • Scancell
  • Scandion Oncology
  • SciClone Pharmaceuticals
  • SciNeuro Pharmaceuticals
  • Seagen
  • Seattle Genetics
  • Seismic Bio
  • Seismic Therapeutic
  • Selecxine
  • Selexis
  • Sensei Biotherapeutics
  • SERB Pharmaceuticals
  • Sernova
  • Serum Institute of India
  • Seven and Eight Biopharmaceuticals
  • SevenScore Pharmaceuticals
  • SFJ Pharmaceuticals
  • Shandong Fontacea Pharmaceutical
  • Sharp HealthCare
  • Shenogen Pharma
  • Shenzhen Chipscreen Biosciences
  • Shionogi
  • SHL Medical
  • SIGA Technologies
  • Simcere Pharmaceuticals
  • Simcha Therapeutics
  • Sino Biological
  • Sirnaomics
  • SK Bioscience
  • Skye Bioscience
  • Solstice Oncology
  • Sonnet BioTherapeutics
  • Sorrento Therapeutics
  • SOTIO
  • Spanish National Research Council
  • Specialised Therapeutics
  • SpikImm
  • STADA Arzneimittel
  • Storm Therapeutics
  • Strata Oncology
  • Sud Investments
  • SunRock Biopharma
  • Surface Oncology
  • Suzhou Connect Biopharmaceuticals
  • Syndax Pharmaceuticals
  • Syngene International
  • Synlogic
  • Synthekine
  • Syracuse University
  • Syros Pharmaceuticals
  • T-Cure Bioscience
  • Taiho
  • TaiMed
  • Takeda Pharmaceutical
  • Talem Therapeutics
  • Tavotek Biotherapeutics
  • TCR2 Therapeutics
  • Telcon RF Pharmaceuticals
  • Telix Pharmaceuticals
  • Tempest Therapeutics
  • Teon Therapeutics
  • Tesaro
  • Tessa Therapeutics
  • Teva Pharmaceutical Industries
  • Teva Pharmaceuticals USA
  • TFF Pharmaceuticals
  • TG Therapeutics
  • Tharimmune
  • The International AIDS Vaccine Initiative
  • The Jackson Laboratory
  • Theramex
  • Thermo Fisher Scientific
  • TILT Biotherapeutics
  • Tiziana Life Sciences
  • Tizona Therapeutics
  • TJ Biopharma
  • TNAX Biopharma
  • TONIX Pharmaceuticals
  • Toregem BioPharma
  • Torque Therapeutics
  • TRACON Pharmaceuticals
  • Transcenta
  • TransThera
  • TrialSpark
  • Trianni
  • Trinomab Biotech
  • Trio Pharmaceuticals
  • Triumvira Immunologics
  • TSB Therapeutics
  • Tsinghua University
  • Tubulis
  • Turgut Ilaclari
  • Twist Bioscience
  • UbiVac
  • UCB
  • Ultragenyx Pharmaceuticals
  • UMass Memorial Medical Center
  • Undisclosed Company
  • UnitedHealth
  • University of Alabama at Birmingham
  • University of Birmingham
  • University of California Los Angeles
  • University of California Riverside
  • University of California San Francisco
  • University of Florida
  • University of Minnesota
  • University of Oxford
  • University of Pennsylvania
  • University of Washington
  • Upadia
  • UroGen Pharma
  • US Army Medical Research and Material Command
  • US Army Medical Research Institute of Infectious Diseases
  • Utrecht University
  • Vaccinex
  • ValenzaBio
  • Vanda Pharmaceuticals
  • Vanderbilt University
  • Vcell Healthcare
  • Velabs Therapeutics
  • Verseau Therapeutics
  • Vetter
  • Viela Bio
  • Vir Biotechnology
  • Viridian Therapeutics
  • Viroclinics Biosciences
  • Visterra
  • Vyera Pharmaceuticals
  • Wellmarker Bio
  • Werewolf Therapeutics
  • WindMIL Therapeutics
  • Windward Bio
  • Wistar Institute
  • WuXi Biologics
  • Wuxi Shuangliang Biotechnology
  • Xbrane Biopharma
  • Xencor
  • XERIS Pharmaceuticals
  • Xilio Therapeutics
  • Xoma
  • Xuanzhu Biopharma
  • Xyphos Biosciences
  • Y-Biologics
  • Y-mAbs Therapeutics
  • Yale University
  • Yarrow Bioscience
  • Yas Holding
  • ZabBio
  • ZAI Laboratory
  • Zenas BioPharma
  • Zenyaku Kogyo
  • Zumutor Biologics
  • Zura Bio
  • Zydus Cadila
  • Zydus Lifesciences
  • Zymedi
  • Zymeworks
  • ZyVersa Therapeutics

Methodology

  • The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
  • The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
  • The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
  • The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
  • The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

The publisher provides comprehensive coverage of the following partnering or deal types:

  • Asset purchase
  • Assignment
  • Co-development
  • Co-market
  • Co-promotion
  • Collaborative R&D
  • Contract service
  • CRADA
  • Cross-licensing
  • Development
  • Distribution
  • Equity purchase
  • Evaluation
  • Grant
  • Joint venture
  • Licensing
  • Loan
  • Manufacturing
  • Marketing
  • Option
  • Promotion
  • Research
  • Royalty financing
  • Settlement
  • Spin out
  • Sub license
  • Supply
  • Termination
  • Warrant

Every deal record is fully categorized and includes the following data, where available:

  • Industry sector
  • Therapy areas
  • Technology type
  • Deal components
  • Financial terms
  • Stage of development
  • Exclusivity
  • Asset type
  • Geographic focus
  • Excluded geography
  • Company press release
  • SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

 

 

Loading
LOADING...